Mesothelioma Cancer Resources Blog
-
Knockout Technology May Lead Researchers to Personalized Mesothelioma Treatments
Sigma Life Sciences, a biotechnology company that offers products for all disciplines of life science research from antibodies to animal models, has announced that they have added new genetically modified cancer cells to their range of high-quality cell lines. They expect that their human knockout and knock-in oncology cell lines will “offer researchers cellular models …
Label: Research News
Posted on Monday, Feb 28, 2011 -
Part II: Managing the Psychosocial Needs of a Mesothelioma Patient – the Medical Provider’s Perspective
by Nancy Meredith For a doctor, management of the issues surrounding a patient’s diagnosis of mesothelioma, or any other incurable cancer, requires careful recordkeeping, meticulous review of tests and constant monitoring of the patient’s health. According to a 2007 breakthrough study conducted by the Institute of Medicine (IOM), physicians should also monitor the social and …
Label: Featured Story
Posted on Friday, Feb 25, 2011 -
Part I: Managing the Psychosocial Needs of a Mesothelioma Patient – the Patient’s Perspective
by Nancy Meredith Being diagnosed with cancer, such as mesothelioma or lung cancer, is overwhelming and often devastating to many of the patients. Not only is the disease physically challenging, but it can also take a toll on the patients’ and their families’ emotional well-being. The average survival time for mesothelioma, a serious cancer that …
Label: Featured Story
Posted on Thursday, Feb 24, 2011 -
Pacific Meso Center to Co-Sponsor Seminar Focused on Malignant Pleural Mesothelioma Lung-Sparing Therapies
The Pacific Meso Center (PMC) at The Pacific Heart, Lung & Blood Institute (PHLBI), a non-profit institution focused on the treatment and prevention of malignant pleural mesothelioma, will help sponsor a UCLA Seminar on Lung-Sparing Therapies for Malignant Pleural Mesothelioma. The first scientific seminar featuring cancer treatments that preserve the victims’ lungs will be held …
Label: Mesothelioma Research News
Posted on Wednesday, Feb 23, 2011 -
Antioxidant Drugs Beneficial for Limiting Tumor Growth in Cancers, May Fight Effects of Mesothelioma-Causing Asbestos
Researchers at Thomas Jefferson Hospital’s Kimmel Cancer Center report that they have found genetic evidence that antioxidant drugs currently used to treat lung disease and the common cold can also be beneficial for treating cancers. Antioxidants fight mitochondrial oxidative stress which has been shown to drive tumor growth. Stopping tumor growth and preventing metastasis in …
Label: Treatment News
Posted on Tuesday, Feb 22, 2011 -
Doctors Should Seek Context for Accurate Mesothelioma Diagnosis
Personalized medicine follows the concept that a patient’s specific characteristics, such as height, weight, gender, age, physical condition and especially their genetic makeup, can be used to tailor their medical care. Personalized medicine is becoming more favored within the medical community, but one study shows that one aspect of personalized care that may be overlooked …
Label: Treatment News
Posted on Monday, Feb 21, 2011 -
Biotech/Life Science Conference to Bring Pharmaceutical Companies and Investors Together, Opportunity to Seek Funding for New Mesothelioma and Cancer Treatments
The Council for Entrepreneurial Development (CED) is once again hosting the Biotech/Life Science Conference in North Carolina where early-stage, small, drug-development companies get an opportunity to network with some of the pharmaceutical giants in the industry. GlaxoSmithKline, Merck, Pfizer and AstraZeneca, as well as many other biotech heavyweights, will meet one-on-one with small companies vying …
Label: Research News
Posted on Friday, Feb 18, 2011 -
Watson Could be the Answer to Fighting Mesothelioma
by Nancy Meredith Anyone that watched the last three nights of “Jeopardy!” should be left in awe at the brain power exhibited by previous million-dollar champions Ken Jennings and Brad Rutter. Although, in the end, they could not compete with the brilliance and speed of their opponent, Watson — a supercomputer made up of 90 …
Label: Featured Story
Posted on Thursday, Feb 17, 2011 -
American Thoracic Society Accepting Applications for Grants, Mesothelioma Researchers May Apply
The deadline to apply for research grants from the American Thoracic Society (ATS) is March 15, 2011. Researchers can apply for unrestricted grant support or specific partnership grants for research in targeted areas, as well as for a 2011 MECOR Research Award which provides small seed funds to the graduates of the ATS MECOR program. …
Label: Mesothelioma Research News
Posted on Wednesday, Feb 16, 2011 -
DNA Damage from Asbestos Exposure Leads to Mesothelioma
Exposure to asbestos is the direct cause of multiple diseases including mesothelioma, asbestosis and lung cancer – with mesothelioma perhaps the most tragic. Mesothelioma is a rare, incurable cancer that occurs in the thin layer of tissue that covers the majority of the body’s internal organs, the mesothelium. Asbestos is a carcinogen, which means that …
Label: Asbestos Mesothelioma
Posted on Tuesday, Feb 15, 2011



